These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9063487)

  • 1. [Antitumor effect and mechanism of a novel multifunctional nucleoside, 3'-ethynylnucleoside, on human cancers].
    Tanaka M; Tabata S; Matsuda A; Fukushima M; Eshima K; Sasaki T
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):476-82. PubMed ID: 9063487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
    Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
    J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
    Takatori S; Kanda H; Takenaka K; Wataya Y; Matsuda A; Fukushima M; Shimamoto Y; Tanaka M; Sasaki T
    Cancer Chemother Pharmacol; 1999; 44(2):97-104. PubMed ID: 10412942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3'-ethynyl nucleosides.
    Murata D; Endo Y; Obata T; Sakamoto K; Syouji Y; Kadohira M; Matsuda A; Sasaki T
    Drug Metab Dispos; 2004 Oct; 32(10):1178-82. PubMed ID: 15280220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic mechanisms of new antitumor nucleoside analogues, 3'-ethynylcytidine (ECyd) and 3'-ethynyluridine (EUrd).
    Kanda H; Takatori S; Matsuda A; Sasaki T; Tanaka M; Fukushima M; Wataya Y
    Nucleic Acids Symp Ser; 1997; (37):137-8. PubMed ID: 9586037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1.
    Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of a novel multifunctional antitumor nucleoside, 3'-ethynylcytidine, on human cancers.
    Tabata S; Tanaka M; Matsuda A; Fukushima M; Sasaki T
    Oncol Rep; 1996 Nov; 3(6):1029-34. PubMed ID: 21594501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
    Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK-PD modeling of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes.
    Takada A; Kamiya H; Shuto S; Matsuda A; Harashima H
    Int J Pharm; 2009 Jul; 377(1-2):52-9. PubMed ID: 19426792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.
    Azuma A; Matsuda A; Sasaki T; Fukushima M
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):609-19. PubMed ID: 11563078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo.
    Kazuno H; Fujioka A; Fukushima M; Wataya Y; Matsuda A; Sasaki T
    Int J Oncol; 2009 May; 34(5):1373-80. PubMed ID: 19360349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
    Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
    Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106).
    Naito T; Yokogawa T; Kim HS; Futagami M; Wataya Y; Matsuda A; Fukushima M; Kitade Y; Sasaki T
    Nucleic Acids Res Suppl; 2002; (2):241-2. PubMed ID: 12903195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory mechanisms of 1-(3-C-ethynyl-beta-D-ribopentofuranosyl)uracil (EUrd) on RNA synthesis.
    Yokogawa T; Naito T; Kanda H; Takatori S; Takenaka K; Sasaki T; Matsuda A; Fukushima M; Kim HS; Wataya Y
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(3):227-32. PubMed ID: 15892261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3'-ethynyluridine-resistant cells.
    Tabata S; Tanaka M; Endo Y; Obata T; Matsuda A; Sasaki T
    Cancer Lett; 1997 Jun; 116(2):225-31. PubMed ID: 9215867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Andersen NK; Jepsen JS; Hansen FG; Haselmann KF; Nielsen C; Wengel J
    Bioorg Med Chem; 2005 Apr; 13(7):2597-621. PubMed ID: 15755661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer molecular mechanism of 3'-ethynylcytidine (ECyd).
    Wataya Y; Futagami M; Naito T; Uchikubo Y; Yokogawa T; Takenaka K; Kim HS; Matsuda A; Fukushima M; Kitade Y
    Nucleic Acids Res Suppl; 2001; (1):233-4. PubMed ID: 12836350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis.
    Matsuda A; Fukushima M; Wataya Y; Sasaki T
    Nucleosides Nucleotides; 1999; 18(4-5):811-4. PubMed ID: 10432683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106.
    Shimamoto Y; Kazuno H; Murakami Y; Azuma A; Koizumi K; Matsuda A; Sasaki T; Fukushima M
    Jpn J Cancer Res; 2002 Apr; 93(4):445-52. PubMed ID: 11985795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.